Jeffrey L. Wade

Insider Reports History

Entity
Individual
Location
8800 Technology Forest Place, The Woodlands, TX
Signature
/s/ Jeffrey L. Wade
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey L. Wade:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. President and COO Common Stock 324K $849K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. President and COO Restricted Stock Units 98.2K $257K $2.62 Feb 28, 2024 Direct
LEXICON PHARMACEUTICALS, INC. President and COO Stock Option (Right to Buy) 307K Jul 8, 2024 Direct

Insider Reports Filed by Jeffrey L. Wade

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXRX LEXICON PHARMACEUTICALS, INC. Jul 8, 2024 1 $0 4 Jul 8, 2024 President and COO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2024 7 -$98.8K 4 Feb 29, 2024 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 8, 2024 2 $0 4 Feb 12, 2024 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Sep 14, 2023 1 $13.8K 4 Sep 14, 2023 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Jun 20, 2023 2 $28K 4 Jun 20, 2023 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2023 7 -$65.7K 4 Mar 1, 2023 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 9, 2023 2 $0 4 Feb 13, 2023 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 28, 2022 7 -$73.5K 4 Feb 28, 2022 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Feb 10, 2022 2 $0 4 Feb 14, 2022 President and CFO
LXRX LEXICON PHARMACEUTICALS, INC. Dec 31, 2021 1 $0 5 Feb 11, 2022 President and CFO